Tatiana Oviedo-Salcedo

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders

Tatiana Oviedo-Salcedo, Lot D. de Witte, Tania Kümpfel et al. · The British Journal of Psychiatry · 2018 · 47 citations · Full text

Life Sciences, Immunology, Psychiatry +17

Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder—A Retrospective Chart Review

Mattia Campana, Johanna Strauß, Susanne Münz et al. · Schizophrenia Bulletin · 2021 · 35 citations · Full text

Medicine, Clinical Sciences, Psychiatry +17

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

Cynthia Okhuijsen‐Pfeifer, Marte Z. van der Horst, Chad Bousman et al. · Translational Psychiatry · 2022 · 32 citations · Full text

Medicine, Genetics, Psychiatry +17

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial

Alkomiet Hasan, Astrid Roeh, Stefan Leucht et al. · Contemporary Clinical Trials Communications · 2020 · 22 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

Bochao Lin, Justo Pinzón-Espinosa, Elodie Blouzard et al. · JAMA Psychiatry · 2022 · 19 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17